Cargando…

Glucose-induced gradual phenotypic modulation of cultured human glomerular epithelial cells may be independent of Wilms’ tumor 1 (WT1)

BACKGROUND: Renal podocytes form the main filtration barrier possessing a unique phenotype maintained by proteins including podocalyxin and nephrin, the expression of which is suppressed in pathological conditions. We used an in vitro model of human glomerular epithelial cells (HGEC) to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsotakos, Nikolaos E, Sagnou, Marina, Kotsopoulou, Eleni S, Tsilibary, Effie C, Drossopoulou, Garyfalia I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686613/ https://www.ncbi.nlm.nih.gov/pubmed/23768159 http://dx.doi.org/10.1186/1471-2121-14-28

Ejemplares similares

High Glucose Impairs Insulin Signaling in the Glomerulus: An In Vitro and Ex Vivo Approach
por: Katsoulieris, Elias N., et al.
Publicado: (2016)

Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway
por: Trohatou, Ourania, et al.
Publicado: (2017)

Liraglutide, a human glucagon‐like peptide‐1 analogue, stimulates AKT‐dependent survival signalling and inhibits pancreatic β‐cell apoptosis
por: Kapodistria, Katerina, et al.
Publicado: (2018)

The Wilms’ tumor (WT1) gene: Methods and protocols
por: Agrawal, Suraksha
Publicado: (2018)

Wilms’ Tumour gene 1 (WT1) as an immunotherapeutic target
por: Coosemans, A.
Publicado: (2011)

Wilms Tumor-1 (WT1) rs16754 Polymorphism
por: Sookaromdee, Pathum, et al.
Publicado: (2019)

Implications of the Wilms’ Tumor Suppressor Wt1 in Cardiomyocyte Differentiation
por: Wagner, Nicole, et al.
Publicado: (2021)

Effect of nanostructured TiO(2) crystal phase on photoinduced apoptosis of breast cancer epithelial cells
por: Lagopati, Nefeli, et al.
Publicado: (2014)

TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels
por: Makki, Mohammad Shahidul, et al.
Publicado: (2008)

Nephron, Wilms’ tumor-1 (WT1), and synaptopodin expression in developing podocytes of mice
por: Kato, Takashi, et al.
Publicado: (2017)

Chemotherapy and terminal skeletal muscle differentiation in WT1‐mutant Wilms tumors
por: Royer‐Pokora, Brigitte, et al.
Publicado: (2018)

Every Beat You Take—The Wilms′ Tumor Suppressor WT1 and the Heart
por: Wagner, Nicole, et al.
Publicado: (2021)

A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation
por: Kaneko, Y, et al.
Publicado: (2015)

Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo
por: Benteyn, Daphné, et al.
Publicado: (2013)

The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific
por: Dafnis, Ioannis, et al.
Publicado: (2016)

Diagnostic utility of Wilms’ tumour-1 protein (WT-1) immunostaining in paediatric renal tumours
por: Goyal, Surbhi, et al.
Publicado: (2016)

Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
por: Busse, Antonia, et al.
Publicado: (2010)

Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
por: Uttenthal, Benjamin, et al.
Publicado: (2014)

Studies of Wilms’ Tumor (WT1) Gene Expression in Adult Acute Leukemias in Singapore
por: Lim, Che Kang, et al.
Publicado: (2007)

The Wilms tumor protein Wt1 contributes to female fertility by regulating oviductal proteostasis
por: Nathan, Abinaya, et al.
Publicado: (2017)

Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2
por: Rapley, E A, et al.
Publicado: (2000)

Wilms’ tumor 1 (WT1) as a prognosis factor in gynecological cancers: A meta-analysis
por: Lu, Jingjing, et al.
Publicado: (2018)

Wilms Tumor-1 (WT1) rs16754 Polymorphism and Clinical Outcome in Acute Myeloid Leukemia
por: Ramzi, Mani, et al.
Publicado: (2019)

Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations
por: Royer-Pokora, Brigitte, et al.
Publicado: (2020)

TERT Expression in Wilms Tumor Is Regulated by Promoter Mutation or Hypermethylation, WT1, and N-MYC
por: Jablonowski, Carolyn M., et al.
Publicado: (2022)

Long-term kidney function in children with Wilms tumour and constitutional WT1 pathogenic variant
por: Falcone, Maria Pia, et al.
Publicado: (2021)

Deletion of WT1 and WIT1 Genes and Loss of Heterozygosity on Chromosome 11p in Wilms Tumors in Japan
por: Kaneko, Yasuhiko, et al.
Publicado: (1993)

The Wilms' Tumor Suppressor Protein WT1 Is Processed by the Serine Protease HtrA2/Omi
por: Hartkamp, Jörg, et al.
Publicado: (2010)

The Wilms’ tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells
por: Brett, Adina, et al.
Publicado: (2013)

Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice
por: Berry, Rachel L., et al.
Publicado: (2015)

Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
por: Oji, Yusuke, et al.
Publicado: (1999)

The Wilms Tumor Gene wt1a Contributes to Blood-Cerebrospinal Fluid Barrier Function in Zebrafish
por: Hopfenmüller, Vera L., et al.
Publicado: (2022)

Cytotoxicity of WT1-reactive T cells against Wilms tumor: An implication for antigen-specific adoptive immunotherapy
por: Monzavi, Seyed Mostafa, et al.
Publicado: (2023)

The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells
por: Han, Youqi, et al.
Publicado: (2007)

Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis
por: Qi, Xiao-wei, et al.
Publicado: (2015)

Testis formation in XX individuals resulting from novel pathogenic variants in Wilms’ tumor 1 (WT1) gene
por: Eozenou, Caroline, et al.
Publicado: (2020)

Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
por: Cowell, J. K., et al.
Publicado: (1993)

PPARβ activation inhibits melanoma cell proliferation involving repression of the Wilms’ tumour suppressor WT1
por: Michiels, Jean-François, et al.
Publicado: (2010)

Oxygen-Dependent Gene Expression in Development and Cancer: Lessons Learned from the Wilms’ Tumor Gene, WT1
por: Scholz, Holger, et al.
Publicado: (2011)

Expression profile of Wilms Tumor 1 (WT1) isoforms in undifferentiated and all-trans retinoic acid differentiated neuroblastoma cells
por: Maugeri, Grazia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l0qmfq55rnb1758kf4ibpbsr74